RenovoRx Inc. (RNXT)
RenovoRx Statistics
Share Statistics
RenovoRx has 36.55M shares outstanding. The number of shares has increased by 48.49% in one year.
| Shares Outstanding | 36.55M |
| Shares Change (YoY) | 48.49% |
| Shares Change (QoQ) | 48.18% |
| Owned by Institutions (%) | 4.06% |
| Shares Floating | 34.93M |
| Failed to Deliver (FTD) Shares | 8.13K |
| FTD / Avg. Volume | 5.93% |
Short Selling Information
The latest short interest is 263.21K, so 0.74% of the outstanding shares have been sold short.
| Short Interest | 263.21K |
| Short % of Shares Out | 0.74% |
| Short % of Float | 0.75% |
| Short Ratio (days to cover) | 2.76 |
Valuation Ratios
The PE ratio is -32.6 and the forward PE ratio is -3.8. RenovoRx's PEG ratio is 0.34.
| PE Ratio | -32.6 |
| Forward PE | -3.8 |
| PS Ratio | 6681.35 |
| Forward PS | 0.6 |
| PB Ratio | 64.16 |
| P/FCF Ratio | -31.44 |
| PEG Ratio | 0.34 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for RenovoRx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.1, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.1 |
| Quick Ratio | 4.1 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $4.3K |
| Profits Per Employee | $-881.4K |
| Employee Count | 10 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -19.01% in the last 52 weeks. The beta is 1.11, so RenovoRx's price volatility has been higher than the market average.
| Beta | 1.11 |
| 52-Week Price Change | -19.01% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 53.15 |
| Average Volume (20 Days) | 137.17K |
Income Statement
In the last 12 months, RenovoRx had revenue of 43K and earned -8.81M in profits. Earnings per share was -0.04.
| Revenue | 43K |
| Gross Profit | 43K |
| Operating Income | -10.97M |
| Net Income | -8.81M |
| EBITDA | -10.97M |
| EBIT | -10.97M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 7.15M in cash and 212K in debt, giving a net cash position of 6.94M.
| Cash & Cash Equivalents | 7.15M |
| Total Debt | 212K |
| Net Cash | 6.94M |
| Retained Earnings | -50.22M |
| Total Assets | 8.12M |
| Working Capital | 5.92M |
Cash Flow
In the last 12 months, operating cash flow was -9.13M and capital expenditures -12K, giving a free cash flow of -9.14M.
| Operating Cash Flow | -9.13M |
| Capital Expenditures | -12K |
| Free Cash Flow | -9.14M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 100%, with operating and profit margins of -25511.63% and -20497.67%.
| Gross Margin | 100% |
| Operating Margin | -25511.63% |
| Pretax Margin | -20497.67% |
| Profit Margin | -20497.67% |
| EBITDA Margin | -25511.63% |
| EBIT Margin | -25511.63% |
| FCF Margin | -21248.84% |
Dividends & Yields
RNXT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for RNXT is $6, which is 512.2% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6 |
| Price Target Difference | 512.2% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -6.65 |
| Piotroski F-Score | 3 |